Reneo Pharmaceuticals, Inc. (RPHM) Reports Q2 Loss of $0.16

Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) reported Q2 EPS of ($0.16), versus ($0.65) reported last year.

For earnings history and earnings-related data on Reneo Pharmaceuticals, Inc. (RPHM) click here.

You May Also Be Interested In

• Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
• XPeng delivers 39,107 vehicles in August, up 4% year-over-year
• StrategX extends private placement deadline to September 30